Correction: Thanks to an eagle-eyed reader, this story has been updated to remove the claim that Dip.io is the first FDA-cleared smartphone urine test. We've reached out to Healthy.io for comment on this development and we'll update when we hear more.
Tel-Aviv, Israel-based Healthy.io has secured FDA 510(k) clearance for Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device.
“We are incredibly proud of being the first to achieve this landmark ruling,” CEO Yonatan Adiri told MobiHealthNews in an email. “It’s the highlight in a year that has seen us achieve so many of the key tasks we set out to achieve. With seven leading medical partners worldwide, including the UK National Healthcare System and a growing product portfolio, we’re set to meet 100,000 patients this year.”
The kit contains detailed instructions for home testing and disposable test strips and testing cups, but the major innovation is a panel of patterns and colors that allows the smartphone camera to accurately read the test strip regardless of lighting or environment. This means that unlike many existing at-home lab kits, patients don't have to mail anything back, and they can get results right away.
Dip.io is already commercialized in Europe and Israel. In the UK, it’s available through a “virtual renal clinic” launched in June by the Salford Royal NHS Foundation Trust. In the US, the company has done a study with National Kidney Foundation and Geisinger Health, demonstrating a feasible use of the platform to improve adherence to care for kidney patients.
“This approval opens the door for improved screening for kidney disease, a condition which affects over 10 percent of the population globally,” Joe Coresh, professor of epidemiology at Johns Hopkins and chair of Healthy.io’s medical advisory board, said in a statement. “Dip.io home testing for protein, glucose, and blood in urine can be enormously helpful for patients. It is also a welcome tool helping improve diagnosis and awareness of chronic kidney disease.”
Healthy.io specializes in healthcare use cases for smartphone-based computer vision. Beyond urine testing, the company is also working on applying that technology to the chronic wound care space.
“We are in the midst of the biggest economic value transition in history,” Adiri, founder and CEO of Healthy.io, said in a statement. “One trillion dollars annually of inefficient healthcare spending in the US alone are now starting to be captured by technology companies that specialize in transparent value creation for less resources. Healthy.io is proud to have its pioneering technology withstand the rigor of FDA Class II trials and continues to pursue its mission of ushering in the era of the medical selfie — as it transforms embedded smartphone cameras into clinical-grade medical scanners.”
While the company has claimed the test is the first of its kind to clear the FDA, public documents show that Scanadu received clearance for a similar product, its Inui In-Home Urine Analysis Test System, previously known as ScanaFlo, in May.
It's also worth noting that the space has a different sort of history with the FDA. A promising and much-touted app with a similar functionality, uChek, was hit with an FDA warning letter for marketing the app without clearance in 2013. Biosense Technologies never did receive clearance for uChek and the app has since been removed from the iOS App Store, though it still appears on Biosense's website.